MbrlCatalogueTitleDetail

Do you wish to reserve the book?
PBK/TOPK interacts with the DBD domain of tumor suppressor p53 and modulates expression of transcriptional targets including p21
PBK/TOPK interacts with the DBD domain of tumor suppressor p53 and modulates expression of transcriptional targets including p21
Hey, we have placed the reservation for you!
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
You are currently in the queue to collect this book. You will be notified once it is your turn to collect the book.
Oops! Something went wrong.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
PBK/TOPK interacts with the DBD domain of tumor suppressor p53 and modulates expression of transcriptional targets including p21
Oops! Something went wrong.
Oops! Something went wrong.
While trying to remove the title from your shelf something went wrong :( Kindly try again later!
Title added to your shelf!
Title added to your shelf!
View what I already have on My Shelf.
Oops! Something went wrong.
Oops! Something went wrong.
While trying to add the title to your shelf something went wrong :( Kindly try again later!
Do you wish to request the book?
PBK/TOPK interacts with the DBD domain of tumor suppressor p53 and modulates expression of transcriptional targets including p21
PBK/TOPK interacts with the DBD domain of tumor suppressor p53 and modulates expression of transcriptional targets including p21

Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
How would you like to get it?
We have requested the book for you! Sorry the robot delivery is not available at the moment
We have requested the book for you!
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
PBK/TOPK interacts with the DBD domain of tumor suppressor p53 and modulates expression of transcriptional targets including p21
PBK/TOPK interacts with the DBD domain of tumor suppressor p53 and modulates expression of transcriptional targets including p21
Journal Article

PBK/TOPK interacts with the DBD domain of tumor suppressor p53 and modulates expression of transcriptional targets including p21

2010
Request Book From Autostore and Choose the Collection Method
Overview
PBK/TOPK (PDZ-binding kinase, T-LAK-cell-originated protein kinase) is a serine-threonine kinase that is overexpressed in a variety of tumor cells but its role in oncogenesis remains unclear. Here we show, by co-immunoprecipitation experiments and yeast two-hybrid analysis, that PBK/TOPK physically interacts with the tumor suppressor p53 through its DNA-binding (DBD) domain in HCT116 colorectal carcinoma cells that express wild-type p53. PBK also binds to p53 mutants carrying five common point mutations in the DBD domain. The PBK–p53 interaction appears to downmodulate p53 transactivation function as indicated by PBK/TOPK knockdown experiments, which show upregulated expression of the key p53 target gene and cyclin-dependent kinase inhibitor p21 in HCT116 cells, particularly after genotoxic damage from doxorubicin. Furthermore, stable PBK/TOPK knockdown cell lines (derived from HCT116 and MCF-7 cells) showed increased apoptosis, G 2 /M arrest and slower growth as compared to stable empty vector-transfected control cell lines. Gene microarray studies identified additional p53 target genes involved in apoptosis or cell cycling, which were differentially regulated by PBK knockdown. Together, these data suggest that increased levels of PBK/TOPK may contribute to tumor cell development and progression through suppression of p53 function and consequent reductions in the cell-cycle regulatory proteins such as p21. PBK/TOPK may therefore be a valid target for antineoplastic kinase inhibitors to sensitize tumor cells to chemotherapy-induced apoptosis and growth suppression.
Publisher
Nature Publishing Group UK,Nature Publishing Group
Subject

631/67/581

/ 631/92/612/1223

/ 692/699/67/1504/1885

/ Apoptosis

/ Apoptosis - genetics

/ Binding proteins

/ Biochemistry

/ Biological and medical sciences

/ Blotting, Western

/ Cell Biology

/ Cell Cycle - genetics

/ Cell physiology

/ Cell Separation

/ Cell transformation and carcinogenesis. Action of oncogenes and antioncogenes

/ Chemotherapy

/ Chromatin Immunoprecipitation

/ Colorectal cancer

/ Colorectal carcinoma

/ Cyclin-dependent kinase

/ Cyclin-dependent kinase inhibitor p21

/ Cyclin-Dependent Kinase Inhibitor p21 - biosynthesis

/ Cyclin-Dependent Kinase Inhibitor p21 - genetics

/ Cyclin-dependent kinases

/ DNA microarrays

/ Dosage and administration

/ Doxorubicin

/ Enzyme inhibitors

/ Flow Cytometry

/ Fundamental and applied biological sciences. Psychology

/ Gene Expression

/ Gene Expression Regulation, Neoplastic

/ Gene Knockdown Techniques

/ Genetic transcription

/ Genetics

/ Genotoxicity

/ GTP-binding protein

/ HCT116 Cells

/ Human Genetics

/ Humans

/ Immunoprecipitation

/ Internal Medicine

/ Kinases

/ Medicine

/ Medicine & Public Health

/ Mitogen-Activated Protein Kinase Kinases

/ Molecular and cellular biology

/ Molecular genetics

/ Mutation

/ Oligonucleotide Array Sequence Analysis

/ Oncology

/ original-article

/ p53 Protein

/ Physiological aspects

/ Properties

/ Protein Interaction Domains and Motifs

/ Protein kinase

/ Protein-Serine-Threonine Kinases - genetics

/ Protein-Serine-Threonine Kinases - metabolism

/ Protein-serine/threonine kinase

/ Regulatory proteins

/ Reverse Transcriptase Polymerase Chain Reaction

/ Signal Transduction

/ Transcription

/ Transcription, Genetic

/ Transcription. Transcription factor. Splicing. Rna processing

/ Tumor cells

/ Tumor suppressor genes

/ Tumor Suppressor Protein p53 - genetics

/ Tumor Suppressor Protein p53 - metabolism

/ Tumorigenesis

/ Two-Hybrid System Techniques